Fycompa is indicated as an adjuvant treatment for partial seizures in patients with epilepsy. Active ingredient: perampanel Prescription medicine
Inovelon is indicated as part of adjunctive therapy in the treatment of epileptic seizures associated with Lennox-Gastaut syndrome in patients over 4 years of age. Active ingredient: rufinamide Prescription medicine.
The drug Keppra is used to treat epilepsy. As monotherapy, as a drug of first choice, it is prescribed for partial seizures of epilepsy with secondary generalization (or without it).
Keppra – injection solution for epileptic seizures. Levetiracetam – the active substance of Keppra is a pyrrolidone derivative (S-enantiomer of α-ethyl-2-oxo-1-pyrrolidine-acetamide), differs in chemical structure from known antiepileptic drugs. Levetiracetam
Lamictal or lamogine contains the active ingredient lamotrigine, which belongs to a group of drugs called antiepileptic drugs. The drug is used to treat two conditions—epilepsy and bipolar disorder. Active
Lyrica is intended for the treatment of neuropathic pain, epilepsy, generalized anxiety disorder, and fibromyalgia. Active ingredient: pregabalin Prescription medicine.
Sabrilan is an antiepileptic drug containing vigabatrin, which increases the concentration of gamma-aminobutyric acid (a major neurotransmitter inhibitor in the brain). Sabrilan, as well as other drugs based on vigabatrin,
The drug Vimpat is used for epilepsy attacks. Used as part of complex therapy for partial convulsive seizures, accompanied or not accompanied by secondary generalization, in patients with epilepsy. Active
Zanegran is an antiepileptic drug. The anticonvulsant activity of zonisamide has been studied in various models of epilepsy, in groups with induced or congenital seizures, and zonisamide has proven itself
Antiepileptic (anticonvulsant) drugs are pharmaceutical substances that reduce the excitability of brain neurons and relieve muscle cramps. Medications for epilepsy do not eliminate the cause of the disease, but control its manifestations, so that a person can lead a full life.
Epilepsy is a chronic noncommunicable disease of the brain that affects people of all ages. Around 50 million people worldwide have epilepsy, making it one of the most common neurological diseases globally. Nearly 80% of people with epilepsy live in low- and middle-income countries.